<DOC>
	<DOCNO>NCT02301221</DOCNO>
	<brief_summary>The purpose study evaluate effect fecal microbiota transplantation adult slow transit constipation .</brief_summary>
	<brief_title>Effect Fecal Microbiota Transplantation Slow Transit Constipation</brief_title>
	<detailed_description>Constipation chronic disease estimate affect 10 % - 15 % worldwide general population . Constipation frequency appear augment increase age , particularly 65 year old . Recent evidence literature collect laboratory confirm constipation consequence intestinal dysbiosis , increase potentially pathogenic microorganism decrease potentially beneficial microorganism . These alteration may affect motility metabolic environment colon , especially production short chain fatty acid ( SCFAs ) . A new under-explored method manipulate gastrointestinal microbiota involve fecal microbiota transplantation ( FMT ) . There grow interest use fecal microbiota treatment patient chronic gastrointestinal infection ( e.g . CDI ) extraintestinal condition ( e.g . IBD ) . Similarly , suppose reshape gut microbiome FMT would effective patient slow transit constipation .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Chronic constipation accord Rome III criterion , define two few spontaneous , complete bowel movement ( SCBMs ) per week minimum 6 month ; Age â‰¥ 18 year ; BMI : 18.525 kg/m2 ; Slow colonic transit confirm colonic transit test ( colonic transit time ( CTT ) &gt; 48 hour ) ; Normal anorectal manometry evidence dyssynergia confirm ability expel rectal balloon ; No radiographic evidence functional ( i.e . pelvic floor dyssynergia ) anatomical ( i.e . significant rectocele intussusception ) impediment expulsion radioopaque contrast ; Disease duration &gt; 1 year ; Traditional treatment dietary modification , laxative ( include osmotic stimulant laxative ) , biofeedback try past 6 month without success ; Bowel constipation due innate factor ( i.e . megacolon ) secondary intervention ( i.e . drug , endocrine , metabolic , neurologic psychologic disorder ) ; History evidence gastrointestinal disease ( i.e . obstruction , cancer , inflammatory bowel disease ) ; Previous abdominal surgery , except cholecystectomy , appendicectomy , tubal ligation cesarean section ; Previous proctological perianal surgery ; A constipation condition meeting Rome III criterion IBS functional abdominal pain syndrome ; Pregnant breastfeed woman ; Infection enteric pathogen ; Usage probiotic , prebiotics and/or synbiotics within last month ; Usage antibiotic and/or PPIs within last 3 month ; Smoking alcohol addiction within last 3 month ; Uncontrolled hepatic , renal , cardiovascular , respiratory psychiatric disease ; Disease therapy drug ( i.e . antidepressant , opioid narcotic analgesic , anticholinergic , calcium antagonist , nitrate , antimuscarinics ) , opinion investigator , could affect intestinal transit microbiota .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Fecal Microbiota Transplantation</keyword>
	<keyword>Slow Transit Constipation</keyword>
	<keyword>Colonic motility</keyword>
</DOC>